Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
TJ210001
DRUG
2 trials
Sponsors
I-Mab Biopharma US Limited
Conditions
Advanced Cancer
Metastatic Cancer
Solid Tumor
Solid Tumor Metastatic Cancer Advanced Cancer
Phase 1
Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors
Completed
NCT04678921
I-Mab Biopharma US Limited
Advanced Cancer, Metastatic Cancer, Solid Tumor
Start: 2020-12-17
End: 2022-11-21
Updated: 2022-12-12
Unknown Phase
Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001
NCT05511350
I-Mab Biopharma US Limited
Solid Tumor Metastatic Cancer Advanced Cancer
Updated: 2022-10-18